Psychotic Disorders  >>  PF-02545920  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-02545920 / Pfizer
NCT00463372: Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Completed
1
40
RoW
PF-02545920
Pfizer
Schizophrenia, Schizo-affective Disorder
 
05/07

Download Options